Analyst Research

Report Title Price
Provider: Edison Investment Research
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Erytech Pharma SA Raises EUR 17.7 Million via Initial Public Offering

Tuesday, 30 Apr 2013 02:35pm EDT 

Erytech Pharma SA announced the results of its initial public offering (IPO) in compartment C of the NYSE Euronext regulated market in Paris. The Company lected to exercise the Extension Clause, thus taking the total amount raised in the IPO (excluding debt compensation) to EUR 16.7 million, with a further EUR 1 million subscribed through debt compensation. The price for the Global Placement and the Open Price Offering was set at the middle of the indicative range, at EUR 11.60. All 1,524,334 new shares offered in the IPO have been subscribed. On the basis of 5,539,952 shares to be admitted for trading and a value of EUR 11.60 per share, Erytech Pharma SA had a market capitalisation of approximately EUR 64.3 million at the conclusion of the IPO. Shares will start trading on May 7, 2013 under the ticker ERYP.